1. Home
  2. PODD vs PSO Comparison

PODD vs PSO Comparison

Compare PODD & PSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Insulet Corporation

PODD

Insulet Corporation

SELL

Current Price

$141.64

Market Cap

10.2B

Sector

Health Care

ML Signal

SELL

Logo Pearson Plc

PSO

Pearson Plc

SELL

Current Price

$18.22

Market Cap

9.8B

ML Signal

SELL

Company Overview

Basic Information
Metric
PODD
PSO
Founded
2000
1844
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Books
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
10.2B
9.8B
IPO Year
2007
2000

Fundamental Metrics

Financial Performance
Metric
PODD
PSO
Price
$141.64
$18.22
Analyst Decision
Buy
Sell
Analyst Count
26
2
Target Price
★ $167.17
$15.70
AVG Volume (30 Days)
★ 1.3M
690.2K
Earning Date
11-04-2026
03-01-2027
Dividend Yield
N/A
★ 1.94%
EPS Growth
N/A
★ N/A
EPS
★ 2.67
N/A
Revenue
★ $2,708,100,000.00
N/A
Revenue This Year
$21.37
$4.02
Revenue Next Year
$13.57
$4.65
P/E Ratio
$51.96
★ $14.05
Revenue Growth
★ 30.73
N/A
52 Week Low
$126.40
$12.02
52 Week High
$354.88
$18.02

Technical Indicators

Market Signals
Indicator
PODD
PSO
Relative Strength Index (RSI) 55.87 81.16
Support Level $139.67 $14.57
Resistance Level $143.45 N/A
Average True Range (ATR) 3.53 0.23
MACD 1.15 0.20
Stochastic Oscillator 86.30 92.51

Price Performance

Historical Comparison
PODD
PSO

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.

About PSO Pearson Plc

UK-listed Pearson is a testing and educational provider. Pearson's primary operations are in assessment and qualifications, testing and higher education, but they also provide English education and testing, virtual learning, prehiring testing and screening, and upskilling/reskilling. The company divested noncore businesses, including the Financial Times, The Economist, and the publishing house Penguin, and is now focused on serving as an educational resource and testing provider.

Share on Social Networks: